Pietro Paolo Vitiello

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

Giulia Martini, Claudia Cardone, Pietro Paolo Vitiello et al. · Molecular Cancer Therapeutics · 2019 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Pietro Paolo Vitiello, Claudia Cardone, Giulia Martini et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience

Pietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta et al. · Cancers · 2019 · 65 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells

Anna Grimaldi, Daniele Santini, Silvia Zappavigna et al. · Cancer Biology & Therapy · 2015 · 61 citations · Full text

Medicine, Oncology, Pharmacology +17